Improved lentiviral vectors for haematopoietic stem cell gene therapy of Mucopolysaccharidosis Type IIIA (MPSIIIA)

被引：0
|
作者：
Sergijenko, A. [1 ]
Langford-Smith, A. [1 ]
Langford-Smith, K. [1 ]
Wynn, R. [2 ]
Wraith, E. [3 ]
Jones, S. [3 ]
Wilkinson, F. [1 ]
Bigger, B. [1 ]
机构：
[1] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England
[2] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England
[3] St Marys Hosp, Manchester M13 0JH, Lancs, England
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A52 / A53
页数：2
相关论文
共 50 条
  • [1] Lentiviral vector-mediated stem cell gene therapy for mucopolysaccharidosis type IIIA (MPSIIIA)
    Langford-Smith, Alex
    Wilkinson, Fiona
    Bennett, William
    Hopwood, John
    Wraith, Ed
    Wynn, Rob
    Bigger, Brian
    HUMAN GENE THERAPY, 2009, 20 (11) : 1396 - 1397
  • [2] Lentiviral Vector-Mediated Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA (MPSIIIA)
    Langford-Smith, A. W. W.
    Wilkinson, F. L.
    Langford-Smith, K. J.
    Bennett, W.
    Howe, S.
    Thrasher, A.
    Hemsley, K.
    Hopwood, J.
    Wraith, J. E.
    Wynn, R. F.
    Bigger, B. W.
    HUMAN GENE THERAPY, 2010, 21 (04) : 502 - 503
  • [3] Lentiviral vector enhanced haematopoietic stem cell gene therapy for mucopolysaccharidosis type IIIA
    Langford-Smith, A.
    Wilkinson, F.
    Langford-Smith, K. J.
    Sergijenko, A.
    Bennett, W.
    Howe, S.
    Thrasher, A.
    Jones, S.
    Wraith, J. E.
    Wynn, R.
    Bigger, B.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S316 - S316
  • [4] Optimisation of Lentiviral Transduction Conditions of Haematopoietic Stem Cells for Treatment of Mucopolysaccharidosis Type IIIA (MPSIIIA)
    Sergijenko, A.
    Langford-Smith, A.
    Langford-Smith, K.
    Wynn, R.
    Wraith, E.
    Wilkinson, F.
    Bigger, B.
    HUMAN GENE THERAPY, 2010, 21 (04) : 518 - 518
  • [5] Development of Lentiviral Mediated Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA
    Ellison, Stuart
    Sergijenko, Ana
    Langford-Smith, Alex
    Langford-Smith, Kia
    Wraith, Ed
    Wynn, Rob
    Wilkinson, Fiona
    Bigger, Brian
    MOLECULAR THERAPY, 2014, 22 : S8 - S8
  • [6] Lentiviral mediated stem cell gene therapy corrects a mouse model of mucopolysaccharidosis type IIIA
    Bigger, Brian
    Langford-Smith, Alex
    Wilkinson, Fiona
    Langford-Smith, Kia
    Sergijenko, Ana
    Wraith, Ed
    Wynn, Rob
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S8 - S8
  • [7] Ex-vivo Autologous Haematopoietic Stem Cell Gene Therapy in Mucopolysaccharidosis Type IIIA
    Kinsella, Jane
    Jones, Simon
    Church, Heather
    Jones, Ceri
    Ellison, Stuart
    Booth, Claire
    Buckland, Karen
    Rico, Diego Leon
    Bigger, Brian
    Thrasher, Adrian J.
    Wynn, Robert
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 320 - 320
  • [8] Preliminary Outcomes of Haematopoietic Stem Cell Gene Therapy in a Patient with Mucopolysaccharidosis IIIA
    Kinsella, Jane
    Buckland, Karen
    Church, Heather
    Duran-Jimenez, Beatriz
    Lee, Helena
    Ellison, Stuart
    Vaz, Fred
    Wijburg, Frits
    Farzaneh, Farzin
    Jones, Simon
    Thrasher, Adrian
    Wynn, Rob
    Bigger, Brian W.
    MOLECULAR THERAPY, 2020, 28 (04) : 231 - 232
  • [9] Pre-clinical workup of lentiviral mediated stem cell gene therapy for mucopolysaccharidosis type IIIA
    Ellison, Stuart M.
    Sergijenko, Ana
    Langford-Smith, Alex
    Langford-Smith, Kia
    Wilkinson, Fiona
    Wynn, Rob
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S41 - S41
  • [10] Pre-clinical workup of lentiviral mediated stem cell gene therapy for mucopolysaccharidosis type IIIA
    Ellison, Stuart
    Sergijenko, Ana
    Langford-smith, Alex
    Langford-smith, Kia
    Wynn, Rob
    Wilkinson, Fiona
    Bigger, Brian
    HUMAN GENE THERAPY, 2015, 26 (09) : A27 - A27
12345